New York, NY -- (SBWIRE) -- 01/23/2014 -- UnitedPenniesofAmerica.com is the #1 Micro-Cap Stock Newsletter for discovering penny stock trading opportunities. We believe the American Penny Stock Market outperforms Emerging Foreign markets which is why our focus leans squarely on American-Only Penny Stocks that appear poised to breakout. We pride ourselves on our ability to discover 'hidden gem' stocks that are 'under-the-radar' before the rest of Wall Street catches on.
To receive our exclusive alerts before the crowd, please visit our WEBSITE (link) or sign up for our SMS Text Message Alerts on your cell phone by texting the word "PENNIES" to number, "69302”.
Here are some hot American stocks to watch: Hokutou Holdings International (OTCMKTS:HKTU), Axxess Pharma (OTCMKTS:AXXE), Sumitomo Mitsui Trust Holdings (OTCMKTS:SUTNY), Entest BioMedical (OTCMKTS:ENTB)
Hokutou Holdings International Inc (OTCMKTS:HKTU), a Japan based company, went down -15.97% and closed at $0.200 with the overall traded volume of 373.32k shares. Stock price 52 weeks high was $85.04. HKTU has total market capitalization of $323,961.
How Should Investors Trade HKTU Now? Don’t Miss out a Special Trend Analysis
Axxess Pharma Inc (OTCMKTS:AXXE), a pharmaceutical company, gained +10.05% in the last trading session and its total traded volume was 393k shares. Stock closed at $0.240. Stock was opened at $0.22 and shares hit a day high of $0.24 and day low of $0.22. Axxess Pharma Inc. offers pharmaceutical products and diagnostic medical devices marketing and distribution services.
Should AXXE a Buy or Sell Now? Find Out Here
Sumitomo Mitsui Trust Holdings Inc (OTCMKTS:SUTNY) traded with the total volume of 122.81k shares in the last trading session. SUTNY moved up +0.19% and its closing price was $5.14. SUTNY has total market cap of $20.02 billion. Its fifty two weeks price range was $3.27-$5.90.
Why Should Investors Buy SUTNY After The Recent Gain? Just Go Here and Find Out
Entest BioMedical Inc. (OTCMKTS:ENTB) reported the gain of +50.00% and closed at $0.0006 in the last trading session and its total traded volume was 168.86 million shares beating the average volume of 9.69 million. ENTB has outstanding shares of 561.86 million. Entest Biomedical, Inc. develops and commercializes immunotherapeutic therapies for the veterinary market.
What was the Moving Force behind ENTB On Bullish Run? Read This Research Report
Tired of missing out on the rallies? Want to gain an extra edge in the market? Visit UnitedPenniesofAmerica.com and subscribe to our Newsletter to receive hot stocks alerts like these BEFORE the rest.
Additionally, we recommend joining our SMS Text Message Alert Service. Grab your cell phone and text the word "PENNIES" to the number, "69302”.
UnitedPenniesofAmerica.com is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list.
The employees of UnitedPenniesofAmerica.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
The information contained in the website and in any reports is provided on an “as-is” basis and has not been verified by us. All information on profiled companies is provided by such companies, or is available from public sources and no representation; warranty or gaurantee is made as to its accuracy or completeness. UnitedPenniesofAmerica.com is under no obligation to update any information or opinions contained herein. Investors should not rely solely on the information presented herein, but rather use such information as a starting point for doing additional independent research on the profiled companies in order to form investment strategies and decisions. Neither UnitedPenniesofAmerica.com nor any of its owners, operators, or affiliates shall be liable to any subscriber or reader for any losses or damages arising from the use of any information contained herein, caused in whole or part by UnitedPenniesofAmerica.com in procuring, compiling, interpreting, reporting, or delivering any of the information contained herein or otherwise delivered.
Read Full Disclaimer at: http://UnitedPenniesofAmerica.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)